Capsulution NanoScience Starts New Feasibility Studies
The studies aim at increasing the bioavailability of several new chemical entities in the human body.
DNT Signs Collaboration Agreement with NCL
NCL will characterize DNT's STARBURST™ dendrimers as macromolecular dendrimer-based MRI contrast agents.
Inpharmatica Licenses Admensa Interactive™ to Mochida
Under the terms of this agreement, Mochida will receive a multi-user license to Admensa Interactive.
Power3 Medical's CSO to Address OncoProteomics World Congress;
Goldknopf to Present Results on Breast Cancer and Leukemia and to Join Conference Scientific Advisory Board.
Galapagos Obtains U.S. Patent Protecting Its Discovery Platform
This patent protects the method of determining the function of a nucleic acid.
Diosynth Announces Agreement with ImmunoGen
Diosynth will manufacture bulk huN901 antibody for ImmunoGen.
Kreido’s STT® Reactor System to Be Utilized by Huntsman
The STT® system improves selectivity, increase yields and initiate chemistries.
Rib-X Granted Key Antibiotic Drug Discovery Patents
The patents describe Rib-X's position on crystal structures of the 50S subunit of the ribosome.
Dharmacon Establishes Genome-Wide RNAi Global Initiative with Research Institutes
The goal of the Global Initiative is to accelerate the scientific and medical discoveries.
Aureus Licenses AurSCOPE® GPCR to Euroscreen
Euroscreen will use Aureus Pharma's technology to identify GPCR drug candidates.